Delayed
Canadian Securities Exchange
11:13:46 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.19
CAD
|
0.00%
|
|
-19.15%
|
-34.48%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Capitalization
1 |
76.95
|
44.3
|
5.081
|
110.5
|
18.35
|
Enterprise Value (EV)
1 |
76.68
|
48.26
|
3.611
|
109.7
|
17.89
|
P/E ratio
|
-6.37
x
|
-2.33
x
|
-0.3
x
|
-3.21
x
|
-0.84
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18.9
x
|
8.79
x
|
-
|
256
x
|
40
x
|
EV / Revenue
|
18.8
x
|
9.57
x
|
-
|
254
x
|
39
x
|
EV / EBITDA
|
-6.79
x
|
-3.94
x
|
-0.77
x
|
-8.98
x
|
-2.32
x
|
EV / FCF
|
-6.51
x
|
-54.9
x
|
-0.62
x
|
146
x
|
-
|
FCF Yield
|
-15.4%
|
-1.82%
|
-161%
|
0.68%
|
-
|
Price to Book
|
4.71
x
|
8.21
x
|
6.67
x
|
41
x
|
2.73
x
|
Nbr of stocks (in thousands)
|
1,145
|
1,247
|
1,672
|
13,415
|
44,747
|
Reference price
2 |
67.20
|
35.52
|
3.040
|
8.240
|
0.4100
|
Announcement Date
|
06/05/19
|
18/08/20
|
28/06/21
|
29/06/22
|
03/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Net sales
1 |
4.081
|
5.042
|
-
|
0.4316
|
0.4585
|
EBITDA
1 |
-11.29
|
-12.25
|
-4.702
|
-12.21
|
-7.721
|
EBIT
1 |
-11.65
|
-17.65
|
-6.599
|
-12.25
|
-7.763
|
Operating Margin
|
-285.57%
|
-350.11%
|
-
|
-2,837.74%
|
-1,693.05%
|
Earnings before Tax (EBT)
1 |
-13.15
|
-21.65
|
-46.9
|
-37.05
|
-15.98
|
Net income
1 |
-12.29
|
-21.46
|
-54.62
|
-37.05
|
-15.98
|
Net margin
|
-301.09%
|
-425.72%
|
-
|
-8,585.16%
|
-3,485.36%
|
EPS
2 |
-10.56
|
-15.25
|
-10.27
|
-2.570
|
-0.4886
|
Free Cash Flow
1 |
-11.77
|
-0.8787
|
-5.827
|
0.7502
|
-
|
FCF margin
|
-288.5%
|
-17.43%
|
-
|
173.82%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/05/19
|
18/08/20
|
28/06/21
|
29/06/22
|
03/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2023
|
---|
Net Debt
1 |
-
|
3.96
|
-
|
-
|
-
|
Net Cash position
1 |
0.27
|
-
|
1.47
|
0.84
|
0.46
|
Leverage (Debt/EBITDA)
|
-
|
-0.323
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-11.8
|
-0.88
|
-5.83
|
0.75
|
-
|
ROE (net income / shareholders' equity)
|
-96.8%
|
-198%
|
-852%
|
-764%
|
-
|
ROA (Net income/ Total Assets)
|
-42.6%
|
-56.8%
|
-30.2%
|
-89.4%
|
-
|
Assets
1 |
28.84
|
37.81
|
180.9
|
41.47
|
-
|
Book Value Per Share
2 |
14.30
|
4.330
|
0.4600
|
0.2000
|
0.1500
|
Cash Flow per Share
2 |
0.3600
|
0.0700
|
0.0400
|
0.0400
|
0.0100
|
Capex
1 |
5.11
|
1.64
|
-
|
0.01
|
0.03
|
Capex / Sales
|
125.25%
|
32.43%
|
-
|
2.01%
|
5.87%
|
Announcement Date
|
06/05/19
|
18/08/20
|
28/06/21
|
29/06/22
|
03/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -34.48% | 6.54M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|